Impact of Fibroblast Growth Factor-23 on Peripheral Arterial Disease in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Pilot Study

Hatipoglu, Pınar; Ozgur, Bilgül; Niyazoglu, Mutlu; Dikici, Atilla; Ekmekci, Ozlem; Yalin, Serkan; Siva, Zeynep; Ilkova, Hasan

doi:10.4274/tjem.3179

Impact of Fibroblast Growth Factor-23 on Peripheral Arterial Disease in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Pilot Study

Hatipoglu E., Ozgur N., Niyazoglu M., Dikici A. S., Ekmekci O. B., Yalin S., ...More

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.19, no.4, pp.119-123, 2015 (ESCI, Scopus)

Publication Type: Article / Article
Volume: 19 Issue: 4
Publication Date: 2015
Doi Number: 10.4274/tjem.3179
Journal Name: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Page Numbers: pp.119-123
Istanbul University Affiliated: Yes

Abstract

Purpose: To evaluate whether fibroblast growth factor-23 (FGF-23) has a common role in the pathogenesis of peripheral arterial disease (PAD) and chronic kidney disease (CKD) in type-2 diabetes mellitus (DM).